The effect of systemic lipoic acid on hearing preservation after cochlear implantation via the round window approach: A guinea pig model

European Journal of Pharmacology

Volumn 799, Issue , 2017, Pages 67-72

  Chang, Mun Young ^a   Gwon, Tae Mok ^b   Lee, Ho Sun ^c   Lee, Jun Ho ^b   Oh, Seung Ha ^b   Kim, Sung June ^b   Park, Min Hyun ^c  

^a Chung Ang University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

Author keywords

Cochlear implantation; Hearing preservation; Lipoic acid; Residual hearing

Indexed keywords

THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY BRAINSTEM RESPONSE; AUDITORY EVOKED POTENTIAL; COCHLEAR IMPLANTATION; CONTROLLED STUDY; ELECTRODE; FIBROSIS; HEARING ACUITY; HEARING PRESERVATION; INNER EAR DISEASE; INTRACOCHLEAR FIBROSIS; MALE; NERVE CELL; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; ANIMAL; COCHLEA FENESTRA; DRUG EFFECTS; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HEARING; PHYSIOLOGY;

ANIMALS; COCHLEAR IMPLANTATION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HEARING; MALE; ROUND WINDOW, EAR; THIOCTIC ACID;

EID: 85011339582     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2017.01.042     Document Type: Article

References (22)

1. Abdin, A.A., Sarhan, N.I., Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of alpha-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity. Neurosci Res 71 (2011), 387–395.
2. Bae, S.C., Jung, W.J., Lee, E.J., Yu, R., Sung, M.K., Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr 28 (2009), 56–62.
3. Choi, C.H., Oghalai, J.S., Predicting the effect of post-implant cochlear fibrosis on residual hearing. Hear Res 205 (2005), 193–200.
4. Connolly, T.M., Eastwood, H., Kel, G., Lisnichuk, H., Richardson, R., O'Leary, S., Pre-operative intravenous dexamethasone prevents auditory threshold shift in a guinea pig model of cochlear implantation. Audiol Neurootol 16 (2011), 137–144.
5. Cui, J., Xiao, Y., Shi, Y.H., Wang, B., Le, G.W., Lipoic acid attenuates high-fat-diet-induced oxidative stress and B-cell-related immune depression. Nutrition 28 (2012), 275–280.
6. Di Pierro, F., Settembre, R., Safety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen. J Pain Res 6 (2013), 497–503.
7. Dinh, C.T., Haake, S., Chen, S., Hoang, K., Nong, E., Eshraghi, A.A., Balkany, T.J., Van De Water, T.R., Dexamethasone protects organ of corti explants against tumor necrosis factor-alpha-induced loss of auditory hair cells and alters the expression levels of apoptosis-related genes. Neuroscience 157 (2008), 405–413.
8. Eastwood, H., Chang, A., Kel, G., Sly, D., Richardson, R., O'Leary, S.J., Round window delivery of dexamethasone ameliorates local and remote hearing loss produced by cochlear implantation into the second turn of the guinea pig cochlea. Hear Res 265 (2010), 25–29.
9. Eshraghi, A.A., Dinh, C.T., Bohorquez, J., Angeli, S., Abi-Hachem, R., Van De Water, T.R., Local drug delivery to conserve hearing: mechanisms of action of eluted dexamethasone within the cochlea. Cochlear Implants Int 12:Suppl 1 (2011), S51–S53.
10. Gantz, B.J., Hansen, M.R., Turner, C.W., Oleson, J.J., Reiss, L.A., Parkinson, A.J., Hybrid 10 clinical trial: preliminary results. Audiol Neurootol 14 Suppl 1 (2009), 32–38.
11. Gantz, B.J., Turner, C., Gfeller, K.E., Lowder, M.W., Preservation of hearing in cochlear implant surgery: advantages of combined electrical and acoustical speech processing. Laryngoscope 115 (2005), 796–802.
12. Haake, S.M., Dinh, C.T., Chen, S., Eshraghi, A.A., Van De Water, T.R., Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Hear Res 255 (2009), 22–32.
13. Havenith, S., Lammers, M.J., Tange, R.A., Trabalzini, F., della Volpe, A., van der Heijden, G.J., Grolman, W., Hearing preservation surgery: cochleostomy or round window approach? A systematic review. Otol Neurotol 34 (2013), 667–674.
14. Lee, J., Ismail, H., Lee, J.H., Kel, G., O'Leary, J., Hampson, A., Eastwood, H., O'Leary, S.J., Effect of both local and systemically administered dexamethasone on long-term hearing and tissue response in a Guinea pig model of cochlear implantation. Audiol Neurootol 18 (2013), 392–405.
15. Moura, F.A., de Andrade, K.Q., dos Santos, J.C., Goulart, M.O., Lipoic Acid: its antioxidant and anti-inflammatory role and clinical applications. Curr Top Med Chem 15 (2015), 458–483.
16. O'Leary, S.J., Monksfield, P., Kel, G., Connolly, T., Souter, M.A., Chang, A., Marovic, P., O'Leary, J.S., Richardson, R., Eastwood, H., Relations between cochlear histopathology and hearing loss in experimental cochlear implantation. Hear Res 298 (2013), 27–35.
17. Podskarbi-Fayette, R., Pilka, A., Skarzynski, H., Electric stimulation complements functional residual hearing in partial deafness. Acta Otolaryngol 130 (2010), 888–896.
18. Quesnel, A.M., Nakajima, H.H., Rosowski, J.J., Hansen, M.R., Gantz, B.J., Nadol, J.B. Jr., Delayed loss of hearing after hearing preservation cochlear implantation: Human temporal bone pathology and implications for etiology. Hear Res 333 (2016), 225–234.
19. Rathmann, W., Haastert, B., Delling, B., Gries, F.A., Giani, G., Postmarketing surveillance of adverse drug reactions: a correlational study approach using multiple data sources. Pharmacoepidemiol Drug Saf 7 (1998), 51–57.
20. Trivedi, P.P., Jena, G.B., Role of alpha-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: studies on inflammation, oxidative stress, DNA damage and fibrosis. Food Chem Toxicol 59 (2013), 339–355.
21. Tsuji, J., Liberman, M.C., Intracellular labeling of auditory nerve fibers in guinea pig: central and peripheral projections. J Comp Neurol 381 (1997), 188–202.
22. Ziegler, D., Low, P.A., Litchy, W.J., Boulton, A.J., Vinik, A.I., Freeman, R., Samigullin, R., Tritschler, H., Munzel, U., Maus, J., Schutte, K., Dyck, P.J., Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 34 (2011), 2054–2060.